---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-331147"
form_type: "8-K"
ticker: "TCRT"
cik: "0001107421"
company_name: "Alaunos Therapeutics, Inc."
filed_at: "2025-12-23T23:59:59+00:00"
generated_at: "2026-05-16T12:13:26.710453+00:00"
event_type: "litigation"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Alaunos Therapeutics settles unpaid invoices with MD Anderson for $285,055

## Summary
- Settlement resolves disputes over $285,055 in unpaid invoices under 2019 R&D agreement with MD Anderson.
- Alaunos to pay in six installments: $142,528 by Dec 30, 2025, then five monthly payments of $28,506 through May 30, 2026.
- Mutual general releases exchanged for claims related to unpaid invoices; ongoing protocol 2006-0676 excluded.
- CEO Holger Weis signed agreement on Dec 15, 2025; effective date Dec 17, 2025.

## SEC filing metadata
- accession: 0001193125-25-331147
- form_type: 8-K
- ticker: TCRT
- cik: 0001107421
- company_name: Alaunos Therapeutics, Inc.
- filed_at: 2025-12-23T23:59:59+00:00
- event_type: litigation
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1107421/000119312525331147/0001193125-25-331147-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1107421/000119312525331147/tcrt-20251217.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-331147
- JSON: https://secwatch.observer/filing/0001193125-25-331147.json
- Plain text: https://secwatch.observer/filing/0001193125-25-331147.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.